Telehealth Narcolepsy Prescribing: What Psychiatric NPs Can Do in California

If you’re a psychiatrist or psychiatric nurse practitioner considering narcolepsy care via telehealth, you’re probably asking yourself: Can I actually prescribe stimulants remotely? What about Schedule II restrictions? Does my state even allow this?

The short answer: Yes, most providers can manage narcolepsy via telehealth — but the details matter. A lot.

Narcolepsy isn’t just another psych diagnosis. It’s a rare neurological sleep disorder affecting roughly 1 in 2,000 Americans, and treating it means navigating controlled substance regulations, state scope-of-practice laws, and telehealth prescribing rules that vary wildly by location. For psychiatrists, the path is relatively straightforward. For PMHNPs, it depends entirely on where you’re licensed.

This article breaks down exactly what you can do, what you can’t, and how to stay compliant while building a sustainable narcolepsy practice through telehealth.

The Controlled Substance Challenge: Federal vs. State Rules

Narcolepsy treatment typically involves prescribing wakefulness-promoting medications — most commonly Schedule II stimulants like Adderall (amphetamine) or Ritalin (methylphenidate), or Schedule IV drugs like modafinil (Provigil). Some patients also need medications for cataplexy (sudden muscle weakness), including sodium oxybate (Xyrem/Xywav), which is both Schedule III and has its own REMS program.

Where Federal Law Stands (2025–2026)

During the COVID-19 public health emergency, the DEA suspended the Ryan Haight Act’s requirement for an in-person exam before prescribing controlled substances via telehealth. That waiver has been extended through December 31, 2025, meaning providers can currently prescribe Schedule II–V medications after a telehealth-only encounter, without ever seeing the patient in person.

This is huge for narcolepsy care. It means a psychiatrist licensed in a patient’s state can conduct a video evaluation, confirm the diagnosis (ideally with sleep study documentation), and initiate stimulant therapy entirely remotely — legally, at the federal level.

What happens after 2025? The DEA is expected to issue new permanent telemedicine prescribing rules. Advocacy groups are pushing for continued flexibility, but there’s no guarantee. Providers should monitor DEA guidance closely and be prepared to adapt — potentially by arranging initial in-person visits through local partnerships or hybrid models.

State Telehealth Laws: The Real Gatekeepers

Federal allowances are only half the story. State laws can be more restrictive — and in some cases, they override federal flexibility.

Florida, for example, prohibits telehealth providers from prescribing Schedule II controlled substances unless the prescription falls under specific exceptions: psychiatric treatment, inpatient care, hospice, or chronic pain management. Since narcolepsy is a neurological condition (not a psychiatric one), Florida providers treating narcolepsy via telehealth technically cannot prescribe Schedule II stimulants under current state law — even though federal rules allow it.

The workaround? Prescribe modafinil (Schedule IV), which Florida’s 2022 telemedicine law permits. Or ensure the patient has at least one in-person evaluation with a local physician.

Texas has no blanket telehealth ban on controlled substances for physicians, so psychiatrists can prescribe narcolepsy meds remotely. But for NPs and PAs, Texas law restricts Schedule II prescribing to hospital inpatient or hospice settings — meaning a Texas PMHNP working in telehealth cannot independently prescribe Adderall for an outpatient narcolepsy patient. They’d need their collaborating physician to write those prescriptions, or stick to Schedule III–V alternatives.

New York, California, Illinois, and Pennsylvania generally allow telehealth prescribing of controlled substances (within federal guidelines), with no additional state-level barriers for psychiatrists. For NPs, scope of practice laws determine what they can prescribe — more on that below.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists: Full Authority, Minimal Friction

If you’re a board-certified psychiatrist (MD or DO) licensed in the patient’s state, your scope to treat narcolepsy via telehealth is essentially unrestricted — assuming you comply with federal DEA rules and any state-specific telehealth requirements.

What Psychiatrists Can Do

• Diagnose and initiate treatment: Review sleep study results (polysomnogram, multiple sleep latency test), take a detailed history, and start first-line medications like modafinil, amphetamines, or methylphenidate.
• Prescribe all narcolepsy medications: Schedule II stimulants, Schedule IV wakefulness agents, antidepressants for cataplexy, and even sodium oxybate (with REMS enrollment).
• Manage comorbidities: Treat co-occurring ADHD, depression, or anxiety in the same visits — a significant advantage over general neurologists who may not address psychiatric symptoms.
• Coordinate care: Work with sleep specialists, primary care doctors, and therapists to provide integrated treatment.

Compliance Essentials

Even with broad authority, psychiatrists must follow specific protocols:

1. PDMP checks: Almost every state requires checking the Prescription Drug Monitoring Program before prescribing controlled substances. New York, for instance, mandates a PDMP query before every controlled substance prescription.

2. Electronic prescribing: Most states now require e-prescribing of controlled substances (EPCS) through DEA-compliant systems. Paper prescriptions for Schedule II drugs are largely obsolete.

3. Documentation: Chart notes must meet the same standard of care as in-person visits — detailed history, exam (within the limits of video), diagnosis, treatment plan, and informed consent.

4. Informed consent for telehealth: Document that the patient consents to telemedicine care and understands its limitations.

5. Identity verification: Confirm the patient’s identity and location (for licensure and emergency purposes).

6. Follow-up frequency: Monthly visits during titration; quarterly at minimum for stable patients. This aligns with Schedule II refill rules (no refills allowed; new prescriptions required each month).

Reimbursement for Psychiatrists

Telehealth parity laws in most states ensure psychiatrists are reimbursed at the same rate as in-person visits. A typical medication management follow-up (15–20 minutes) would be coded as 99213 (established patient, low complexity) or 99214 (moderate complexity if adjusting treatment or managing side effects).

Medicare allowable rates: ~$80–$100 for 99213; ~$110–$130 for 99214 (varies by locality).

Private insurance: Often pays $120–$160 for 99214, though mental health providers have historically been reimbursed about 22% less than other physicians for comparable services — a disparity many states are addressing through parity legislation.

Cash-pay alternative: Some psychiatrists opt out of insurance entirely, charging patients $100–$200 per follow-up. Narcolepsy patients, especially those in underserved areas, may be willing to pay out-of-pocket for specialized telehealth care.

With monthly visits standard for narcolepsy medication management, a single patient can generate $1,000–$1,500 annually in reimbursement (before overhead). Multiply that by 20–30 narcolepsy patients in your panel, and you’ve got a stable, predictable income stream.

PMHNPs: State-by-State Authority (and Restrictions)

Psychiatric-Mental Health Nurse Practitioners have varying authority to prescribe narcolepsy medications depending on state scope-of-practice laws. In some states, experienced PMHNPs function identically to psychiatrists. In others, they’re significantly restricted — or even prohibited from prescribing the primary medications narcolepsy requires.

Full Practice States (Near-Parity with MDs)

New York: After 3,600 hours of supervised practice (about 2 years), PMHNPs no longer need a collaborative agreement with a physician. They can prescribe Schedule II–V controlled substances independently, including stimulants for narcolepsy. New York made this permanent in 2022.

California: NPs can achieve full independence under AB 890 after completing 3 years (or 4,600 hours) of practice in a physician-supervised group setting (‘103 NP’ status). By January 2026, those NPs become ‘104 NPs’ with completely independent practice authority, including prescribing Schedule II narcolepsy medications without any physician oversight. Before reaching independence, California NPs can prescribe stimulants under standardized procedures with a collaborating physician.

Illinois: PMHNPs with Full Practice Authority (FPA) — achieved after 4,000 hours of collaborative practice + 250 hours of continuing education — can prescribe narcolepsy medications independently. Illinois law requires physician consultation only for long-term opioid or benzodiazepine prescribing (beyond 120 days for benzos); stimulants are not restricted. Experienced Illinois PMHNPs are essentially on par with psychiatrists for narcolepsy care.

Restricted Practice States (Significant Limitations)

Texas: PMHNPs must have a Prescriptive Authority Agreement with a supervising physician. More critically, Texas law prohibits NPs from prescribing Schedule II drugs for outpatients — with narrow exceptions for hospital inpatient care or hospice. This means a Texas PMHNP cannot prescribe Adderall or Ritalin for a narcolepsy patient in telehealth or clinic settings. They can prescribe modafinil (Schedule IV) under their agreement, but would need their collaborating physician to write any Schedule II prescriptions.

Florida: PMHNPs must practice under a physician collaborative agreement (Florida’s autonomous NP law excludes psychiatric NPs). NPs can prescribe Schedule II drugs, but with a 7-day supply limit — unless they’re certified psychiatric nurses prescribing for psychiatric conditions. This creates a gray area for narcolepsy: technically a neurological disorder, not psychiatric, so the 7-day limit likely applies. Practically, this means a Florida PMHNP would need to write four separate prescriptions per month to cover a patient’s stimulant needs — or rely on their supervising psychiatrist for ongoing stimulant scripts.

Pennsylvania: PMHNPs require a written collaborative agreement with a physician. They can prescribe Schedule II drugs for up to a 30-day supply (with 24-hour physician notification), and Schedule III–IV for up to 90 days. Beyond those limits, physician involvement is required. While this aligns with typical narcolepsy follow-up schedules (monthly visits for stimulants), it’s more administratively burdensome than an MD’s authority.

State-by-State Summary Table

The Economics: Why Narcolepsy Care Makes Sense

Treating narcolepsy via telehealth isn’t just clinically rewarding — it’s financially viable.

Patient Demand is High, Supply is Low

Narcolepsy affects roughly 160,000 Americans, many of whom are underdiagnosed or undertreated. Sleep specialists (the traditional go-to for narcolepsy) are scarce: there are only about 7,000 board-certified sleep medicine physicians in the U.S., and they’re concentrated in urban areas. Rural and suburban patients often wait months for an appointment.

Psychiatrists and PMHNPs can fill this gap — especially for medication management (as opposed to initial diagnostic workups, which require sleep studies). Many narcolepsy patients are referred to psychiatry for comorbid ADHD or depression; treating their narcolepsy in the same practice is a natural extension.

Predictable, Recurring Revenue

Narcolepsy isn’t a one-time consult. It’s a chronic condition requiring:

• Monthly visits during titration (2–4 months)
• Quarterly visits for stable patients (at minimum)
• Ongoing prescription renewals (Schedule II = no refills)

A single narcolepsy patient generates $1,000–$1,500 per year in reimbursement. Build a panel of 20–30 patients, and that’s $20,000–$45,000 in annual recurring revenue — with relatively short (15–20 minute) visits that fit easily into telehealth schedules.

No Patient Acquisition Costs (With the Right Platform)

Here’s where most solo practitioners or DIY telehealth setups fall short: patient acquisition is expensive.

• SEO takes 6–12 months of consistent investment before generating meaningful patient flow — most providers don’t have the expertise or budget.
• Google Ads for mental health keywords cost $15–$40+ per click, and most clicks don’t convert. Realistic cost per booked patient: $200–$400+.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees ($30–$100+) and you compete with hundreds of other providers on the same page.
• Total DIY marketing spend: $3,000–$5,000/month with uncertain results.

Klarity Health eliminates this risk entirely.

We use a pay-per-appointment model: you pay a standard listing fee only when a qualified, pre-screened patient books with you. No upfront marketing spend. No wasted ad budgets. No subscription fees.

You control your schedule. We handle patient acquisition, credentialing, telehealth infrastructure, and billing support. For narcolepsy specifically, we match you with patients who’ve already confirmed their diagnosis (or need a medication management provider after seeing a sleep specialist) — meaning higher conversion rates and fewer wasted appointments.

The math is simple: Instead of gambling $5,000/month on marketing with no guarantee of results, you pay only when you see patients. That’s guaranteed ROI.

Medication Management Workflow: What a Typical Visit Looks Like

Here’s how most providers structure narcolepsy medication management via telehealth:

Initial Evaluation (30–45 minutes)

• Review sleep study results (polysomnogram, MSLT) — typically sent by patient or referring provider
• Detailed history: symptom onset, sleep attacks, cataplexy episodes, impact on daily function
• Screen for comorbidities: ADHD, depression, anxiety
• Physical health review: cardiovascular history (important for stimulants), current medications, substance use
• Informed consent for telehealth and controlled substance prescribing
• Diagnosis confirmation and treatment plan
• Prescribe initial medication (often modafinil or low-dose stimulant)
• Schedule follow-up in 2–4 weeks

Billing: 99205 (new patient, high complexity) or 99204 (moderate) — typically $200–$300 reimbursement.

Follow-Up Visits (15–20 minutes)

• Symptom update: Epworth Sleepiness Scale, sleep attack frequency, cataplexy episodes
• Side effect monitoring: blood pressure, heart rate, appetite, sleep quality at night
• Medication adjustment: dose titration, switching agents if needed
• PDMP check (if prescribing controlled substance)
• Refill prescription (monthly for Schedule II)
• Schedule next visit

Billing: 99213 or 99214 — $80–$130 reimbursement.

Quarterly Maintenance (Once Stable)

• Comprehensive review: overall function, work/school performance, quality of life
• Lab work review if needed (liver function for some meds)
• Insurance prior authorization renewals (for medications like modafinil or oxybate)
• Long-term treatment plan discussion

Common Provider Questions (FAQ)

Can I prescribe narcolepsy medications without a sleep study?

Technically yes, but it’s not recommended. Standard of care for narcolepsy diagnosis requires objective sleep testing (polysomnogram + multiple sleep latency test). If a patient comes to you without documentation, you should refer them for testing before initiating stimulant therapy — both for clinical accuracy and to avoid regulatory scrutiny (prescribing Schedule II stimulants without a confirmed diagnosis raises red flags).

Many patients will already have their diagnosis from a neurologist or sleep specialist and are seeking ongoing medication management — this is the ideal scenario for telehealth psychiatry.

Do I need to see narcolepsy patients in person at some point?

Not currently (through 2025), thanks to the DEA’s extended telehealth allowance. After that, it depends on what regulations the DEA finalizes. Some states may also impose their own in-person requirements for controlled substance prescribing.

Best practice: Build relationships with local clinics or primary care providers who can conduct periodic in-person evaluations if needed — this creates a hybrid model that satisfies compliance while maintaining telehealth efficiency.

What if my state restricts Schedule II prescribing via telehealth?

Use modafinil or armodafinil (Schedule IV wakefulness agents) as first-line, which are permitted via telehealth in nearly all states. These are often equally effective, especially for narcolepsy without cataplexy.

If a patient requires amphetamines and your state prohibits telehealth prescribing, coordinate with a local physician for that specific prescription while you manage the rest of their care remotely.

How do I handle prior authorizations for expensive narcolepsy meds?

Prior auths are a reality for modafinil, Sunosi (solriamfetol), Wakix (pitolisant), and especially sodium oxybate (Xyrem/Xywav). Most require:

• Documentation of confirmed narcolepsy diagnosis (sleep study results)
• Trial of first-line therapy (e.g., modafinil before approving Sunosi)
• Chart notes demonstrating medical necessity

Many platforms (including Klarity) offer administrative support for prior authorizations — our team can help prepare and submit paperwork, saving you 30–60 minutes per patient.

What about the ongoing stimulant shortage?

The Adderall shortage that began in 2022 has been partially resolved, but periodic supply issues continue. Telehealth gives you flexibility: you can quickly e-prescribe alternative stimulants (methylphenidate, lisdexamfetamine) or switch to modafinil if needed.

Communication is key: warn patients in advance that shortages may occur, and have backup treatment plans ready.

Can PMHNPs in Texas treat narcolepsy at all?

Yes, but with limitations. Texas PMHNPs cannot prescribe Schedule II stimulants for outpatients — so they’d need to:

• Prescribe modafinil (Schedule IV) under their Prescriptive Authority Agreement, OR
• Work in a collaborative model where their supervising psychiatrist writes amphetamine prescriptions

Either way, the PMHNP can still provide the clinical management, patient education, and follow-up care — just not the Schedule II scripts independently.

Why Join Klarity’s Provider Network?

We’ve built our telehealth platform specifically to solve the pain points providers face when treating conditions like narcolepsy:

✅ Pre-qualified patient leads — we match you with patients who’ve confirmed their diagnosis or are referred by sleep specialists
✅ No upfront marketing costs — you pay only when a patient books with you
✅ Integrated telehealth platform — HIPAA-compliant video, e-prescribing (EPCS-enabled), EHR documentation
✅ Credentialing and billing support — we handle insurance paneling and claims submission
✅ Multi-state licensing support — we guide you through obtaining licenses in high-demand states
✅ Prior authorization assistance — our admin team helps prepare documentation for expensive meds
✅ Flexible scheduling — you control when and how much you work

Most importantly: you’re not alone. Many providers on our platform treat narcolepsy, ADHD, and other conditions requiring controlled substance prescribing. We’ve built workflows, compliance protocols, and peer support networks to make this work — safely, legally, and profitably.

The Bottom Line

Narcolepsy prescribing via telehealth is legally and clinically feasible for most psychiatrists and many PMHNPs — but the specifics depend heavily on your state’s laws and your scope of practice.

Psychiatrists: You have the broadest authority. As long as you’re licensed in the patient’s state, follow DEA and state telehealth rules, and document appropriately, you can provide comprehensive narcolepsy care remotely.

PMHNPs: Your ability to treat narcolepsy depends on where you’re licensed. In full-practice states like New York, Illinois, and (soon) California, experienced NPs can function identically to psychiatrists. In restricted states like Texas and Florida, you’ll need physician collaboration or be limited to non-Schedule II alternatives.

Either way, the demand is real. Narcolepsy patients are underserved, especially outside major metro areas. Telehealth solves access barriers — and platforms like Klarity make it financially sustainable by eliminating marketing risk and providing the infrastructure you need to focus on patient care.

Ready to explore treating narcolepsy patients via telehealth? Join Klarity’s provider network and start seeing qualified patients within weeks — no marketing budget required.

References & Citations

1. Axios (Nov 18, 2024). ‘COVID-era telehealth prescribing extended again through end of 2025.’ Reports DEA/HHS extension of Ryan Haight Act waiver. Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

2. Texas Medical Board (2025). ‘Who can prescribe Schedule II drugs under physician delegation?’ Official FAQ confirming Texas NP/PA Schedule II restrictions (hospital/hospice only). Available at: https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation

3. California Board of Registered Nursing (2024). ‘AB 890 Implementation – Nurse Practitioner Practice.’ Details 103/104 NP categories and timeline for independent practice. Available at: https://www.rn.ca.gov/practice/ab890.shtml

4. Florida Statutes, Section 464.012 (2021). Nurse Practice Act – outlines 7-day Schedule II limit for APRNs and psychiatric nurse exception. Available at: https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All

5. Rivkin Radler LLP (Apr 13, 2022). ‘New Law Allows Experienced NPs to Practice Independently in NY.’ Summary of NY Education Law amendment making NP independence permanent after 3,600 hours. Available at: https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/

6. 49 Pa. Code §21.284 (Pennsylvania Nursing Code). Official regulations detailing NP prescribing limitations (30-day Schedule II, 90-day Schedule III–IV). Available at: https://www.pacodeandbulletin.gov/Display/pacode?file=/secure/pacode/data/049/chapter21/s21.284.html

7. Illinois Nurse Practice Act, 225 ILCS 65/65-43 (2018). Establishes Full Practice Authority for NPs and consultation requirements for Schedule II narcotics/benzodiazepines. Available at: https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act

8. KFF Health News via MedicalXpress (Jan 3, 2024). ‘Patients with narcolepsy face a dual nightmare of medication shortages and stigma.’ Reports narcolepsy prevalence (1 in 2,000) and ongoing Adderall shortage. Available at: https://medicalxpress.com/news/2024-01-patients-narcolepsy-dual-nightmare-medication.html

9. Axios San Antonio (Aug 7, 2024). ‘Texas ranks last in US for mental health access.’ Cites Mental Health America data on Texas workforce shortages. Available at: https://www.axios.com/local/san-antonio/2024/08/07/texas-churches-religion-mental-health-response

10. Axios Chicago (Mar 6, 2025). ‘Illinois bill could make mental health care more affordable by hiking reimbursement rates.’ Reports 22% lower reimbursement for mental health providers vs. other physicians. Available at: https://www.axios.com/local/chicago/2025/03/06/illinois-mental-health-bill-reimbursement-rates

11. Clinical Advisor (Feb 10, 2012). ‘Is Medicare’s 85% reimbursement rule fair?’ Confirms Medicare pays NPs/PAs at 85% of physician fee schedule. Available at: https://www.clinicaladvisor.com/home/the-waiting-room/is-medicares-85-reimbursement-rule-fair/

12. National Law Review (Apr 7, 2022). ‘New Florida Law Allows Telemedicine Prescribing of Controlled Substances – With Exceptions.’ Analysis of Florida SB 312 and Schedule II telehealth restrictions. Available at: https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances

13. NYS Education Department (2013, updated). ‘Collaborative Practice with Physicians – Nurse Practitioners.’ Official guidance on collaborative agreement requirements. Available at: https://www.op.nysed.gov/professions/nurse-practitioners/practice-issues/collaborative-practice-with-physicians

14. Axios (Aug 1, 2023). ‘Biden administration targets mental health parity, behavioral health workforce shortages.’ Cites Psychiatric Services journal data on psychiatrist shortage (31,000 deficit by 2024). Available at: https://www.axios.com/2023/08/01/biden-mental-health-parity-behavioral-workforce-shortages

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority